Training activity information
Details
Interpret haematological assays to inform testing strategies, to include:
- CML
- AML
- MPN
- ALL
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
- Clinical presentation features
- Correlation with full blood counts, including morphology, immunophenotyping, and histopathology
- Limitations and comparison of methodologies
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Select the relevant testing strategy for commonly referred haematological malignancies, including CML, AML, MPN and ALL. |
| # 3 |
Outcome
Evaluate the urgency of testing for particular haematological malignancies to inform management decisions. |
| # 6 |
Outcome
Practice with the relevant specialities for the diagnosis, monitoring and management of haematological malignancies. |